Will the LNP-mRNA Therapy Market Reach USD 719 Million by 2034 at a 6.1% CAGR? According to a new report from Intel Market Research, the global LNP-mRNA Therapy market was valued at USD 500 million in 2026 and is projected to reach USD 719 million by 2034, growing at a CAGR of 6.1% during the forecast period (2026–2034). This growth is propelled by the success of mRNA-based COVID-19 vaccines, increasing investments in genetic medicine infrastructure, and expansion into non-vaccine therapeutic applications. https://www.intelmarketresearch.com/download-free-sample/6809/lnp-mrna-therapy-market